Market Cap

Abbisko Cayman Ltd Market Capitalization:

HK$9.43 Billion

HKD as of Jan. 1, 2026

US$1.21 Billion

business Abbisko Cayman Ltd Company Profile

Abbisko Cayman Ltd Main Stock Listing

HKEX: 2256

Market Capitalization History of Abbisko Cayman Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Abbisko Cayman Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2026 HK$9.43 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Abbisko Cayman Ltd Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Abbisko Cayman Ltd has the following listings and related stock indices.


Stock: HKEX: 2256

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.